ストックスクリーナーアプリを入手
1.19
11.21%
0.12
前日終値:
$1.07
開ける：
$1.09
24時間の取引高:
350.50K
Relative Volume:
2.08
時価総額：
$23.28M
収益：
$411.00K
当期純損益:
$-4.85M
株価収益率:
-2.7045
EPS:
-0.44
ネットキャッシュフロー:
$-4.88M
1週間 パフォーマンス:
+15.53%
1か月 パフォーマンス:
+42.77%
6か月 パフォーマンス:
-17.36%
1年 パフォーマンス:
-66.19%
1日の値動き範囲:
$1.06
$1.34
1週間の範囲:
$0.97
$1.34
52週間の値動き範囲:
$0.7749
$3.565
Lexaria Bioscience Corp Stock (LEXX) Company Profile
名前
Lexaria Bioscience Corp
セクター
電話
250-765-6424
住所
100 - 740 MCCURDY ROAD, KELOWNA
LEXX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
1.19 | 19.75M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexaria Bioscience Corp (LEXX) 最新ニュース
Quantitative breakdown of Lexaria Bioscience Corp. Equity Warrant recent moveTrade Performance Summary & Low Drawdown Investment Ideas - Newser
Sector ETF performance correlation with Lexaria Bioscience Corp.2025 Big Picture & Technical Buy Zone Confirmation - Newser
Ranking Lexaria Bioscience Corp. among high performing stocks via toolsMarket Trend Review & Growth Focused Stock Reports - Newser
Chart based analysis of Lexaria Bioscience Corp. trendsWeekly Earnings Recap & Low Volatility Stock Suggestions - Newser
Can Lexaria Bioscience Corp. Equity Warrant hit a new high this monthMarket Growth Summary & Real-Time Volume Trigger Notifications - Newser
Real time scanner hits for Lexaria Bioscience Corp. explained2025 AllTime Highs & Verified Chart Pattern Trade Signals - Newser
Multi asset correlation models including Lexaria Bioscience Corp.July 2025 EndofMonth & Reliable Price Action Trade Plans - Newser
Will Lexaria Bioscience Corp. Equity Warrant see short term momentumMarket Trend Review & Smart Swing Trading Alerts - Newser
Published on: 2025-09-12 17:52:14 - Newser
Identifying reversal signals in Lexaria Bioscience Corp. Equity Warrant2025 Support & Resistance & Daily Oversold Bounce Ideas - Newser
Should you hold or exit Lexaria Bioscience Corp. nowJuly 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
Using RSI to spot recovery in Lexaria Bioscience Corp.Earnings Miss & Free Reliable Trade Execution Plans - Newser
Published on: 2025-09-12 13:51:40 - Newser
Using AI based signals to follow Lexaria Bioscience Corp.Share Buyback & Free Reliable Trade Execution Plans - Newser
What institutional flow reveals about Lexaria Bioscience Corp. Equity Warrant2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Can momentum traders help lift Lexaria Bioscience Corp.Take Profit & Weekly High Potential Alerts - Newser
Is Lexaria Bioscience Corp. trending in predictive chart modelsJuly 2025 Gainers & Consistent Growth Equity Picks - Newser
Combining price and volume data for Lexaria Bioscience Corp.Risk Management & Expert Approved Momentum Trade Ideas - Newser
Can machine learning forecast Lexaria Bioscience Corp. recoveryBear Alert & Safe Capital Growth Tips - Newser
Analyzing Lexaria Bioscience Corp. Equity Warrant with multi timeframe chartsTrade Ideas & Fast Exit and Entry Strategy Plans - Newser
Will Lexaria Bioscience Corp. stock recover after recent dropJuly 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Backtesting results for Lexaria Bioscience Corp. Equity Warrant trading strategiesQuarterly Trade Review & Capital Efficient Trading Techniques - Newser
Comparing Lexaria Bioscience Corp. in custom built stock radarsMarket Activity Report & Daily Oversold Bounce Ideas - Newser
Advanced analytics toolkit walkthrough for Lexaria Bioscience Corp. Equity WarrantLong Setup & Fast Gain Swing Trade Alerts - Newser
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference - Investing News Network
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone - Investing News Network
Will Lexaria Bioscience Corp. Equity Warrant rebound enough to break evenWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
Applying Elliott Wave Theory to Lexaria Bioscience Corp.2025 Earnings Impact & Accurate Intraday Trading Signals - Newser
What recovery options are there for Lexaria Bioscience Corp.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser
Real time scanner hits for Lexaria Bioscience Corp. Equity Warrant explained - Newser
Lexaria Bioscience Corp.’s volatility index tracking explainedQuarterly Profit Report & Real-Time Volume Analysis - Newser
Full technical analysis of Lexaria Bioscience Corp. stockEarnings Performance Report & Reliable Breakout Forecasts - Newser
Using R and stats models for Lexaria Bioscience Corp. Equity Warrant forecasting2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
What Fibonacci levels say about Lexaria Bioscience Corp. rebound2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser
Is it time to cut losses on Lexaria Bioscience Corp.Market Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
Combining price and volume data for Lexaria Bioscience Corp. Equity WarrantJuly 2025 Market Mood & Safe Entry Momentum Tips - Newser
What earnings revisions data tells us about Lexaria Bioscience Corp. Equity Warrant2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Has Lexaria Bioscience Corp. Equity Warrant formed a bullish divergenceInsider Buying & Expert-Curated Trade Recommendations - Newser
Relative strength of Lexaria Bioscience Corp. Equity Warrant in sector analysisEarnings Growth Report & Free Fast Gain Swing Trade Alerts - Newser
Using Bollinger Bands to evaluate Lexaria Bioscience Corp.Weekly Trend Report & Low Risk High Reward Trade Ideas - Newser
Is a relief rally coming for Lexaria Bioscience Corp. holdersJuly 2025 Analyst Calls & Weekly High Momentum Picks - Newser
Leading vs lagging indicators on Lexaria Bioscience Corp. performanceDip Buying & Intraday High Probability Setup Alerts - Newser
Will Lexaria Bioscience Corp. Equity Warrant outperform tech stocksPortfolio Performance Summary & Growth Oriented Trade Recommendations - Lancaster City Council
Lexaria Bioscience Corp (LEXX) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):